Raptor, Aix-Marseille University, French National Institute of Health and Medical Research (INSERM), Institut Curie deal

Raptor received exclusive, worldwide rights to develop and commercialize cysteamine and related compounds to treat Rett syndrome and associated disorders of methyl CpG binding protein 2 ( MECP2; RTT...